227
Participants
Start Date
November 24, 1997
Primary Completion Date
May 1, 2002
Study Completion Date
February 10, 2009
clodronate disodium
mitoxantrone hydrochloride
prednisone
quality-of-life assessment
Tom Baker Cancer Center - Calgary, Calgary
Penticton Regional Hospital, Penticton
British Columbia Cancer Agency - Fraser Valley Cancer Centre, Surrey
B.C. Cancer Agency, Vancouver
Saint John Regional Hospital, Saint John
Newfoundland Cancer Treatment and Research Foundation, St. John's
Nova Scotia Cancer Centre, Halifax
Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton
Kingston Regional Cancer Centre, Kingston
Cancer Care Ontario-London Regional Cancer Centre, London
Trillium Health Centre, Mississauga
Ottawa Regional Cancer Center - General Division, Ottawa
Peterborough Oncology Clinic, Peterborough
Hotel Dieu Hospital - St. Catharines, St. Catharines
Northwestern Ontario Regional Cancer Centre, Thunder Bay, Thunder Bay
Toronto Sunnybrook Regional Cancer Centre, Toronto
Princess Margaret Hospital, Toronto
Humber River Regional Hospital, Weston
Cancer Care Ontario - Windsor Regional Cancer Centre, Windsor
Queen Elizabeth Hospital, PEI, Charlottetown
McGill University Department of Oncology, Montreal
Lead Sponsor
NCIC Clinical Trials Group
NETWORK